Scientific Opinion on Dietary Reference Values for molybdenum

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the...

Full description

Bibliographic Details
Main Author: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Format: Article
Language:English
Published: Wiley 2013-08-01
Series:EFSA Journal
Subjects:
Online Access:http://www.efsa.europa.eu/en/efsajournal/doc/3333.pdf
id doaj-90f5e9d732b946cd9507950fb03d3046
record_format Article
spelling doaj-90f5e9d732b946cd9507950fb03d30462021-05-02T14:01:43ZengWileyEFSA Journal1831-47322013-08-0111810.2903/j.efsa.2013.3333Scientific Opinion on Dietary Reference Values for molybdenumEFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the regulation of excretion via the urine. Molybdenum deficiency in otherwise healthy humans has not been observed and there are no biomarkers of molybdenum status. Various metabolic balance studies have been performed to establish molybdenum requirements. However, only one balance study, which was performed with a constant diet and under controlled conditions in adult men, was considered to be of sufficient duration. In this small study, balance was reported to be near zero when molybdenum intakes were 22 µg/day. Biochemical changes or symptoms suggestive of molybdenum deficiency were not observed, and it is possible that humans may be able to achieve molybdenum balance at even lower intakes. Data on molybdenum intakes and health outcomes were unavailable for the setting of DRVs for molybdenum. As the evidence required to derive an Average Requirement and a Population Reference Intake was considered insufficient, an Adequate Intake (AI) is proposed. Observed molybdenum intakes from mixed diets in Europe were taken into consideration in setting this value. An AI of 65 µg/day is proposed for adults; a figure that is based on molybdenum intakes at the lower end of the wide range of observed intakes. It is suggested that the adult AI also applies to pregnant and lactating women. An AI is also proposed for infants from seven months and for children based on extrapolation from the adult AI using isometric scaling and the reference body weights of the respective age groups.http://www.efsa.europa.eu/en/efsajournal/doc/3333.pdfmolybdenumAdequate IntakeDietary Reference Value
collection DOAJ
language English
format Article
sources DOAJ
author EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
spellingShingle EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Scientific Opinion on Dietary Reference Values for molybdenum
EFSA Journal
molybdenum
Adequate Intake
Dietary Reference Value
author_facet EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
author_sort EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
title Scientific Opinion on Dietary Reference Values for molybdenum
title_short Scientific Opinion on Dietary Reference Values for molybdenum
title_full Scientific Opinion on Dietary Reference Values for molybdenum
title_fullStr Scientific Opinion on Dietary Reference Values for molybdenum
title_full_unstemmed Scientific Opinion on Dietary Reference Values for molybdenum
title_sort scientific opinion on dietary reference values for molybdenum
publisher Wiley
series EFSA Journal
issn 1831-4732
publishDate 2013-08-01
description Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the regulation of excretion via the urine. Molybdenum deficiency in otherwise healthy humans has not been observed and there are no biomarkers of molybdenum status. Various metabolic balance studies have been performed to establish molybdenum requirements. However, only one balance study, which was performed with a constant diet and under controlled conditions in adult men, was considered to be of sufficient duration. In this small study, balance was reported to be near zero when molybdenum intakes were 22 µg/day. Biochemical changes or symptoms suggestive of molybdenum deficiency were not observed, and it is possible that humans may be able to achieve molybdenum balance at even lower intakes. Data on molybdenum intakes and health outcomes were unavailable for the setting of DRVs for molybdenum. As the evidence required to derive an Average Requirement and a Population Reference Intake was considered insufficient, an Adequate Intake (AI) is proposed. Observed molybdenum intakes from mixed diets in Europe were taken into consideration in setting this value. An AI of 65 µg/day is proposed for adults; a figure that is based on molybdenum intakes at the lower end of the wide range of observed intakes. It is suggested that the adult AI also applies to pregnant and lactating women. An AI is also proposed for infants from seven months and for children based on extrapolation from the adult AI using isometric scaling and the reference body weights of the respective age groups.
topic molybdenum
Adequate Intake
Dietary Reference Value
url http://www.efsa.europa.eu/en/efsajournal/doc/3333.pdf
work_keys_str_mv AT efsapanelondieteticproductsnutritionandallergiesnda scientificopinionondietaryreferencevaluesformolybdenum
_version_ 1721490862262714368